Abstract
Depressive Symptoms (DS) are a serious condition that negatively impacts the features of being and survival rates of people with advanced Breast Cancer (BC). Among the most common types of cancer that affect women globally is BC. Despite substantial improvements in identification and treatment, BCS often deals with various medical, psychological, and emotional difficulties. The overall health and quality of life of Breast Cancer Survivors (BCS) are negatively impacted by DS, becoming a serious issue. To ascertain the Prevalence and Predictors (PAP) of DS among BCS and identify relevant variables related to the development, this study intended to present a Systematic Review (SR) and Meta-Analysis (MA). To find research from January 2005, a thorough systematic search of Scopus, Science Direct, Google Scholar (GS), Pub Med, Web of Science (WS), American Doctoral Dissertations (ADD), and Open Grey Databases (OGD) was carried out. These 1220 participants were evaluated in 10 qualifying trials for depressive symptoms; 460 patients satisfied the requirements. The PMP of depression was 37%, as per the random-effects model. DS was more common in patients with metastatic stage than recurrent BCP. The developed BCP includes a sizeable PAP of DS. As BCPs begin getting treatment from their initial diagnosis and receive continuing assistance and counseling to meet their Mental Health (MH) needs, it is crucial to build psychological preventative measures to minimize the PAP of depression.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
